🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study was to assess the immunogenicity and safety of two...
Status
Completed
Location
06 Kosin University Gospel Hospital 34, amnam-dong
Start Date
2013-11
Trial ID
NCT01973218
The purpose of this study is to evaluate the safety and immunogenicity of B...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-27
Trial ID
NCT03621670
Primary :1.To demonstrate a sufficient immune response of rMenB+OMV NZ, whe...
Status
Completed
Location
Novartis Investigational Site Nr. 59
Start Date
2008-08
Trial ID
NCT00721396
The proposed study will evaluate the safety of the rMenB+OMV NZ in an adult...
Status
Completed
Location
UOC Medicina Interna 2, Azienda Ospedaliera Universitaria Senese
Start Date
2013-05
Trial ID
NCT01478347
Treatments Being Tested
The proposed study V72P6E1 is an Extension Study of V72P6 (NCT00381615). Th...
Status
Completed
Location
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital
Start Date
2010-01
Trial ID
NCT01027351
The purpose of this study was to evaluate the effectiveness of 2 doses or 3...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-08-14
Trial ID
NCT04502693
The purpose of this study was to collect large volumes of matched pairs of ...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-03-08
Trial ID
NCT03493919
Treatments Being Tested
This extension study V72P12E1 will investigate the safety, tolerability and...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00944034
Treatments Being Tested
This study was aimed to explore safety and immunogenicity of two formulatio...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00381615
The purpose of this trial was to evaluate the effect of Novartis Vaccine's ...
Status
Completed
Location
Clinical Research Center, University of Surrey
Start Date
2010-09
Trial ID
NCT01214850